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It was not too long ago that replying “Cytokines” to the question “What’s your area of research?” elicited
a puzzled look from most researchers. It is a clear sign of how much things have changed that, towards the
end of 2011, a PubMed search with the word “cytokines” comes up with about half a million hits and a
Google search generates a 4-million-plus list. It now seems that everybody, not just biomedical scientists,
know something about cytokines. And yet there is so much more we need to understand.
Cytokines are small proteins that act as messengers between cells, carrying information that inﬂu-
ences and determines a vast variety of functions, from directing embryonic development to maintaining ho-
meostasis, from signaling to neurons to modulating bone structure [1]. But cytokines are most famous
for their role as mediators and regulators of inﬂammatory responses [2]. With chronic inﬂammation being
recognized as the main underlying pathophysiological mechanism of the majority of diseases affecting
vast swaths of the world population, from infections to joint degeneration, from atherosclerosis to diabetes,
cancer,autoimmunityandmanymore,itisnosurprisethatresearchintotheroleandregulationofcytokines,
one of the most important family of inﬂammatory mediators, is on a constant rise. New cytokines are dis-
covered,new functions for old ones unraveled,and new mechanisms of action clariﬁed seemingly everyday.
This special issue of TheScientiﬁcWorldJOURNAL includes reviews and primary research articles
on two aspects of cytokine biology that are being recognized as playing critical roles in the regulation of
inﬂammation and chronic pathologies. The ﬁrst section of this special issue deals with the inﬂammasome
and the interleukin (IL)-1 family of cytokines, whereas the second section discusses aspects of adipokines
and adipose tissue biology.
Interleukin-1, one of the ﬁrst cytokines to be described and cloned, is currently a pharmacological
target for treatment of several conditions [3, 4]. However, despite having been known for decades, several
aspects of IL-1 biology are still puzzling. In particular, the mechanisms leading to activation by proteolytic
cleavage and subsequent release of the mature and active moiety of one of the two types of IL-1, IL-1β,
have been under scrutiny since the molecule was discovered and initially characterized as lacking the typical
signal sequence of secreted proteins [5]. We now understand that a complex multimolecular machinery
known as the inﬂammasome activates caspase-1, the main enzyme responsible for cleavage of pro-IL-
1β (and the structurally similar IL-18) into the active form [6]. Inﬂammasomes are also responsible for
induction of pyroptosis, a recently described type of programmed cell death that clears the body of infected
cells[7].TworeviewarticlesinthisspecialissueofTheScientiﬁcWorldJOURNALdescribetheinvolvement
of the inﬂammasome in disease. The paper by M. Sahoo and colleagues reviews the mechanisms leading to
activation of the inﬂammasome, release of IL-1β and IL-18, and induction of pyroptosis in the context of
bacterial infections, whereas the paper by D. Lissner and B. Siegmund reviews the multifaceted involvement
of the inﬂammasome in the pathogenesis of inﬂammatory bowel disease, a chronic inﬂammatory condition
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of the gastrointestinal tract. The third paper of the ﬁrst section, by A.–M. Balau et al., presents results of
primary research on one of the newest members of the IL-1 family of cytokines, IL-37, and its involvement
in acute inﬂammatory liver disease. As a whole, the three papers of this section highlight the necessity
to learn more about the complexities of the inﬂammasome and the ever-expanding family of IL-1-like
cytokines before targeted therapeutic intervention can be developed.
The second section of this special issue contains papers on adipose tissue and adipokines. Despite
being considered for a long time as a mostly inert tissue, simply devoted to energy storage, adipose tissue is
now clearly identiﬁed as a pivotal contributor to body homeostasis and to the propensity to develop diseases
such as diabetes, atherosclerosis, cancer and many more [8]. The worldwide epidemic of obesity is pushing
scientists to better understand the connection between adipose tissue biology and mechanisms of disease.
Adipokines are a family of cytokines produced by cells present in adipose tissue, that is, adipocytes and
inﬁltrating inﬂammatory cells [9]. Adipokines, including leptin, adiponectin, IL-6 and many more, regulate
several aspects of biology such as food intake, glucose and lipid metabolism, angiogenesis and so forth. Evi-
dence is rapidly accumulating that adipokines and adipose tissue are critical determinants of disease suscep-
tibility and that obesity increases morbidity through dysregulation of adipose tissue function and adipokine
production. The paper by M. Scotece and colleagues in this issue of The Scientiﬁc World discusses evidence
implicating adipokines in the regulation of the inﬂammatory response in rheumatic diseases, thus linking
adipokine production to autoimmune conditions. Two primary research articles also belong to this second
section. The paper by M.-H. Nguyen et al. investigates the involvement of the adipokine leptin and of
its receptor in regulating tissue regeneration following muscle damage, while the paper by L. Tussing-
Humphreys and colleagues evaluates regulation of hepcidin, a major modulator of iron metabolism, in
adipose tissue. These three papers together report on the far-reaching effects of molecules mostly produced
by adipose tissue and the potential unexpected consequences of adipose tissue dysfunction in obesity.
As disparate as the topics of the two sections of this special issue appear to be, the IL-1 family of
cytokines,theinﬂammasome,adipokines,andadiposetissuebiologyareactuallyconnected,withmolecules
and mediators discussed in the ﬁrst section emerging as important modulators of adipose tissue biology,
while adipokines and adipocytes presented in section two modulate production and activity of the protag-
onists of section one [10]. It seems that cytokines are breaking the barriers between disciplines that tradi-
tionally dealt with one tissue, cell, or response at a time and are pulling the body back together as a whole.
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